Ignite Creation Date:
2025-12-24 @ 3:02 PM
Ignite Modification Date:
2026-02-25 @ 4:56 PM
Study NCT ID:
NCT03878459
Status:
RECRUITING
Last Update Posted:
2025-07-01
First Post:
2019-03-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dapagliflozin Plus Pioglitazone in T1DM
Sponsor:
The University of Texas Health Science Center at San Antonio
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HSC20180515H
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None